Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15651)

• Formulation Name: Olanzapine 2.5 mg tablet
• Company: NCS HealthCare of KY, Inc dba Vangard Labs

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Olanzapine	(DMPFN6Y)	Bipolar depression		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Crospovidone	(E00626)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent